Urologic Oncology

What Urologic Oncology does

Urologic Oncology: Seminars and Original Investigations is a peer-reviewed academic journal and the official publication of the Society of Urologic Oncology, published by Elsevier B.V. — a privately held Dutch subsidiary of RELX Group. The journal addresses clinical and basic science research across urologic oncology, including prostate, bladder, kidney, and other genitourinary malignancies, and serves practicing urologists, urologic oncologists, medical oncologists, radiologists, and academic and clinical researchers. Each issue combines original research articles, survey pieces with short commentaries, in-depth Seminar reviews examining specific clinical dilemmas, and periodic supplements on areas of current interest. Distribution is exclusively digital through Elsevier's ScienceDirect platform, with both subscription access for institutions and individuals and an open access option priced at a USD 3,270 article publishing charge. The journal's standing in the field is reflected in a 2.8 Impact Factor and a 4.6 CiteScore, and it operates within Elsevier's Oncology Journal Network for cross-promotion. Editorial operations are small (1–10 staff) under Editor-in-Chief Jodi Maranchie, MD, based in Pittsburgh, with a leadership transition announced for 2025.

Name

Urologic Oncology

Legal name

Elsevier B.V.

Website

https://urologiconcology.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Urologic Oncology: Seminars and Original Investigations is a peer-reviewed academic journal and the official publication of the Society of Urologic Oncology, published by Elsevier and serving clinicians and researchers in urologic oncology.

Ownership category

akta.pro rank

Product category

Academic Medical Publishing

akta.pro primary industry

Urologic Oncology (HLAKAOAB)

akta.pro secondary industries

Genitourinary Oncology (HLAKAFAM), Conference Proceedings & Research Reports Publishing (EDAGAFAL)

Keywords

• Academic journal publishing
• Urologic oncology research
• Peer-reviewed medical journal
• Open access publishing
• Clinical research publication

Headquarters

HQ city

Rochester

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Subscription Revenue: Academic institutions, libraries, and individual subscribers pay for access to the journal's content through Elsevier subscription model. Published articles are immediately available to subscribers.
2. Open Access Article Publishing Charges (APC): Authors pay USD 3,270 (excluding taxes) to publish their article in open access, making it freely available to all readers worldwide. This is a one-time fee per article.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Urologic Oncology: Seminars and Original Investigations is a peer-reviewed academic journal that publishes practical, timely, and relevant clinical and basic science research articles addressing any aspect of urologic oncology, including prostate, bladder, kidney, and other genitourinary malignancies. The journal is the official publication of the Society of Urologic Oncology and is distributed through Elsevier's ScienceDirect digital platform under both subscription-based and open access publishing models.

Product overview

Urologic Oncology: Seminars and Original Investigations is an academic journal that serves as the official publication of the Society of Urologic Oncology. The journal operates as a single unified publication offering, though it publishes various content types including original research articles, review articles, survey articles, and in-depth seminar examinations covering clinical dilemmas in urologic oncology. The journal also periodically publishes special issues and supplement issues devoted to areas of current interest, and offers both subscription-based and open access publishing models.

Differentiator

Problem solved

Functional benefit

Products and services

• Urologic Oncology: Seminars and Original Investigations Peer-reviewed academic journal publishing practical, timely, and relevant clinical and basic science research articles addressing any aspect of urologic oncology, including original research, review seminars, survey articles, and in-depth seminar examinations of clinical dilemmas. Official journal of the Society of Urologic Oncology, distributed globally via Elsevier's ScienceDirect.
• Open Access Article Publishing Open access publication option allowing authors to pay an Article Publishing Charge (USD 3,270, excluding taxes) to make their articles freely available to all readers worldwide immediately upon publication. Authors may qualify for reduced APCs during submission.

Quantifiable outcome

• 4.6 CiteScore indicating strong citation frequency
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Society of Urologic Oncology (SUO)coreStrategic or Co-development PartnerThe journal is the official publication of the Society of Urologic Oncology. This partnership provides the journal with authoritative standing in the field, direct access to the society's membership as potential authors and readers, and alignment with SUO's educational mission and professional standards.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Bladder Cancer: A focused journal specifically on bladder cancer research and treatment, overlapping with a major urologic oncology subspecialty. Comparable as a more narrowly focused oncology journal that addresses the same author community for bladder cancer submissions.

Direct peers

• BJU International: Official journal of the British Association of Urological Surgeons, publishing clinical and laboratory research in urology. Comparable as a peer-reviewed urology journal with significant urologic oncology content targeting an overlapping international readership.
• European Urology: The flagship journal of the European Association of Urology, publishing original research across all urology subspecialties including urologic oncology. Directly comparable as a peer-reviewed urology/urologic oncology journal targeting an overlapping clinician-researcher audience.
• Nature Reviews Urology: Nature Portfolio's review-focused journal covering urology including urologic oncology research. Comparable as a high-prestige specialty journal targeting the same clinical and research audience with a review-oriented content model.
• Journal of Urology: Official journal of the American Urological Association, covering clinical and basic research in urology including urologic oncology. Directly comparable as a high-impact specialty journal serving the same clinician-researcher community with overlapping scope.
• Urology (Gold Journal): Published by Elsevier on behalf of the Société Internationale d'Urologie, providing broad coverage of urology including urologic oncology. Directly comparable as a peer-reviewed specialty journal distributed through the same ScienceDirect platform with overlapping author and reader base.
• Prostate Cancer and Prostatic Diseases: Nature Portfolio's specialty journal focused specifically on prostate cancer and prostatic diseases, a core urologic oncology subspecialty. Comparable as a focused oncology journal addressing one of the same primary cancer types covered by Urologic Oncology.

Broad incumbents

• Cancer: Published by the American Cancer Society on behalf of Wiley, covering multidisciplinary oncology research including urologic malignancies. Comparable as a broad-scope oncology journal with overlapping subject matter and author pool.
• Annals of Surgical Oncology: The official journal of the Society of Surgical Oncology, publishing research on surgical cancer treatment including urologic oncology surgery. Comparable as a broader oncology journal with overlapping content on surgical management of GU malignancies.
• Journal of Clinical Oncology: The flagship clinical oncology journal of the American Society of Clinical Oncology, publishing high-impact cancer research across all tumor types including genitourinary malignancies. Comparable as a broader oncology journal that regularly publishes the same high-tier urologic oncology research this journal also targets.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/urologic-oncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Urologic Oncology